We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

151 hedge funds and large institutions have $299M invested in Definium Therapeutics in 2024 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 39 increasing their positions, 24 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more call options, than puts

Call options by funds: $14.4M | Put options by funds: $3.77M

63% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 27

63% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 24

12% more funds holding

Funds holding: 135 → 151 (+16)

9% less capital invested

Capital invested by funds: $327M → $299M (-$28.2M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

26.45% less ownership

Funds ownership: 84.24% → 57.79% (-26%)

Holders
151
Holders Change
+16
Holders Change %
+11.85%
% of All Funds
2.18%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
44
Increased
39
Reduced
24
Closed
27
Calls
$14.4M
Puts
$3.77M
Net Calls
+$10.6M
Net Calls Change
-$11.6M

Top Buyers

1
BlackRock
BlackRock
New York
+$40.1M
2
State Street
State Street
Massachusetts
+$14.7M
3
CC
Commodore Capital
New York
+$11.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$10.3M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.84M

Top Sellers

1
GPP
Great Point Partners
Connecticut
-$18.8M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$8.11M
3
SCM
Soleus Capital Management
Connecticut
-$7.05M
4
DTC
Deep Track Capital
Connecticut
-$4.92M
5
Millennium Management
Millennium Management
New York
-$3.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
Carson Wealth (CWM LLC)
101
Carson Wealth (CWM LLC)
Nebraska
$9K -$2.34K -268 -17%
OWA
102
Opal Wealth Advisors
New York
$7.94K +$9.63K +1,101 New
PA
103
Parallel Advisors
California
$5.18K +$6.12K +700 +3,684%
NS
104
NBC Securities
Alabama
$4K – – –
HI
105
Harbour Investments
Wisconsin
$3.29K +$1.55K +177 +63%
NL
106
NVWM LLC
Pennsylvania
$3K – – –
CIBC Private Wealth Group
107
CIBC Private Wealth Group
Georgia
$2.89K -$96 -11 -3%
TIM
108
Tortoise Investment Management
New York
$2.88K – – –
AWM
109
Avior Wealth Management
Nebraska
$2.87K +$3.27K +374 +1,558%
Northwestern Mutual Wealth Management
110
Northwestern Mutual Wealth Management
Wisconsin
$2.78K +$149 +17 +5%
EL
111
EMFO LLC
Florida
$2.16K – – –
WWM
112
Wolff Wiese Magana
California
$1.49K +$1.8K +206 New
NA
113
NewEdge Advisors
Louisiana
$1.07K – – –
BCV
114
Banque Cantonale Vaudoise
Switzerland
$1K +$577 +66 New
AFG
115
Albion Financial Group
Utah
$952 – – –
NMG
116
New Millennium Group
Utah
$721 +$875 +100 New
FFA
117
Farther Finance Advisors
California
$707 – – –
HWM
118
HighMark Wealth Management
Minnesota
$562 +$437 +50 +179%
AF
119
Allworth Financial
California
$524 – – –
S
120
SignatureFD
Georgia
$490 – – –
AF
121
Arrow Financial
New York
$476 – – –
HCM
122
Hollencrest Capital Management
California
$476 – – –
WIM
123
Westside Investment Management
California
$476 – – –
AWM
124
Activest Wealth Management
Florida
$476 +$577 +66 New
TCM
125
Tradewinds Capital Management
Washington
$383 – – –
3 4
5
6 7

DFTX Hedge Fund Activity: Q2 2024 in Review

151 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q2 2024, worth a combined $299M — down 8.6% from $327M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new DFTX positions and 27 closed out — a net gain of 17 holders — while 39 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock, adding an estimated $40.1M. The largest seller was Great Point Partners, exiting entirely with an estimated $18.8M sold.

  • 151 institutional investors held Definium Therapeutics (DFTX) as of Q2 2024, up from 135 in Q1 2024.
  • Funds reported $299M of Definium Therapeutics stock for Q2 2024, down 8.6% quarter-over-quarter.
  • 44 funds opened new Definium Therapeutics positions in Q2 2024 and 27 closed out, a net change of +17 holders.
  • The largest Definium Therapeutics buyer in Q2 2024 was BlackRock, an estimated $40.1M added.
  • The largest Definium Therapeutics seller in Q2 2024 was Great Point Partners, an estimated $18.8M sold.

Based on aggregated 13F filings for Q2 2024.